A Global Health Crossroads: WHO's Conditional Embrace of Ozempic-Class Drugs for Obesity
GLP-1 Medications: A Game-Changer, But Not a Solo Act – The WHO Weighs In
United We Stand: Crafting a Path Forward in the Face of Breast Cancer